Company Achieves Clinical Development Milestones in 2025, Advances Program for Future Scale Up and Studies AUSTIN, Texas, Jan. 7, 2026 /PRNewswire/ -- Genprex, Inc.

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the ...

For a decade after its discovery, CRISPR gene editing was stuck on the cusp of transforming medicine. Then, in 2023, scientists started using it on sickle-cell disease, and Victoria Gray, a patient ...

MOST STORIES about gene-edited children begin with He Jiankui, a rogue Chinese scientist who, in 2018, announced that he had created the world’s first such babies in secret. His reckless and illegal ...

Discover how scientists are harnessing the power of CRISPR to precisely edit DNA, revolutionizing medicine and ethics as they rewrite the very code of life. Pixabay, PublicDomainPictures CRISPR ...

Entrepreneurs say it’s time to safety-test designer baby technology. A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create ...

Share on Pinterest Experts say California’s new affordable insulin program is a breakthrough for people with diabetes. Getty Images California has launched a program to manufacture and sell lower-cost ...

When Sunny Vohra acquired Twickenham Film Studios in 2012, he inherited more than just soundstages and post-production facilities. He became the custodian of a 113-year-old institution where cinema ...

Oct 6 (Reuters) - AstraZeneca (AZN.L), opens new tab has signed a $555 million deal with a San Francisco-based biotech business Algen Biotechnologies, The Financial Times reported on Monday. The ...

Sept 26 (Reuters) - Biotech company Factor Bioscience sued rival Cellectis (ALCLS.PA), opens new tab and pharmaceutical giant AstraZeneca (AZN.L), opens new tab in Delaware federal court on Friday for ...